Published in Oncol Lett on May 24, 2017
The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell (2001) 2.22
FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Res (2013) 1.76
The Foxc2 transcription factor regulates tumor angiogenesis. Biochem Biophys Res Commun (2010) 1.11
A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol (2011) 1.06
FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma. Ann Surg Oncol (2010) 1.06
Prox1 and FOXC2 act as regulators of lymphangiogenesis and angiogenesis in oral squamous cell carcinoma. PLoS One (2014) 1.00
Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: clinical experience and review of literature. World J Surg Oncol (2011) 0.99
Evolutionary genomics of the Fox genes: origin of gene families and the ancestry of gene clusters. Genomics (2009) 0.98
PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells. J Exp Clin Cancer Res (2012) 0.98
The cell proliferation antigen Ki-67 organises heterochromatin. Elife (2016) 0.89
Foxc2 overexpression enhances benefit of endothelial progenitor cells for inhibiting neointimal formation by promoting CXCR4-dependent homing. J Vasc Surg (2011) 0.86
Possible prognostic significance of p53, cyclin D1 and Ki-67 in the second primary malignancy of patients with double primary malignancies. Int J Clin Exp Pathol (2014) 0.83
Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression. BMC Cancer (2016) 0.83
Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth. Oncogene (2016) 0.80
Cyclin D1 expression in Bowen's disease and cutaneous squamous cell carcinoma. Mol Clin Oncol (2014) 0.80
The Role of p16, p21, p27, p53 and Ki-67 Expression in the Differential Diagnosis of Cutaneous Squamous Cell Carcinomas and Keratoacanthomas: An Immunohistochemical Study. Balkan Med J (2016) 0.79